Cargando…

Functional Dissection of the TBK1 Molecular Network

TANK-binding kinase 1 (TBK1) and inducible IκB-kinase (IKK-i) are central regulators of type-I interferon induction. They are associated with three adaptor proteins called TANK, Sintbad (or TBKBP1) and NAP1 (or TBKBP2, AZI2) whose functional relationship to TBK1 and IKK-i is poorly understood. We pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goncalves, Adriana, Bürckstümmer, Tilmann, Dixit, Evelyn, Scheicher, Ruth, Górna, Maria W., Karayel, Evren, Sugar, Cristina, Stukalov, Alexey, Berg, Tiina, Kralovics, Robert, Planyavsky, Melanie, Bennett, Keiryn L., Colinge, Jacques, Superti-Furga, Giulio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169550/ https://www.ncbi.nlm.nih.gov/pubmed/21931631 http://dx.doi.org/10.1371/journal.pone.0023971

Ejemplares similares

Initial characterization of the human central proteome
por: Burkard, Thomas R, et al.
Publicado: (2011)

Affinity Purification Strategies for Proteomic Analysis of Transcription Factor Complexes
por: Giambruno, Roberto, et al.
Publicado: (2013)

Experimental characterization of the human non-sequence-specific nucleic acid interactome
por: Dürnberger, Gerhard, et al.
Publicado: (2013)

The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response
por: Soulat, Didier, et al.
Publicado: (2008)

The lysine methyltransferase SMYD3 interacts with hepatitis C virus NS5A and is a negative regulator of viral particle production
por: Eberle, Carol-Ann, et al.
Publicado: (2014)

CD14 is a coreceptor of Toll-like receptors 7 and 9
por: Baumann, Christoph L., et al.
Publicado: (2010)

Proteome-wide small molecule and metabolite interaction mapping
por: Huber, Kilian V. M., et al.
Publicado: (2015)

Stereospecific targeting of MTH1 by (S)-crizotinib as anticancer strategy
por: Huber, Kilian V. M., et al.
Publicado: (2014)

Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action
por: Babak, Maria V., et al.
Publicado: (2015)

IFITs: Emerging Roles as Key Anti-Viral Proteins
por: Vladimer, Gregory I., et al.
Publicado: (2014)

Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms
por: Li, Jiannong, et al.
Publicado: (2013)

A time-resolved molecular map of the macrophage response to VSV infection
por: Kandasamy, Richard K, et al.
Publicado: (2016)

A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
por: Li, Jiannong, et al.
Publicado: (2010)

Introduction to Computational Proteomics
por: Colinge, Jacques, et al.
Publicado: (2007)

A Computational Approach to Analyze the Mechanism of Action of the Kinase Inhibitor Bafetinib
por: Burkard, Thomas R., et al.
Publicado: (2010)

Structural basis for viral 5′-PPP-RNA recognition by human IFIT proteins
por: Abbas, Yazan M., et al.
Publicado: (2013)

A Target-Disease Network Model of Second-Generation BCR-ABL Inhibitor Action in Ph+ ALL
por: Rix, Uwe, et al.
Publicado: (2013)

Building and exploring an integrated human kinase network: Global organization and medical entry points()
por: Colinge, Jacques, et al.
Publicado: (2014)

The SH2 Domain Regulates c-Abl Kinase Activation by a Cyclin-Like Mechanism and Remodulation of the Hinge Motion
por: Dölker, Nicole, et al.
Publicado: (2014)

MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
por: Skucha, Anna, et al.
Publicado: (2018)

A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain
por: Wojcik, John, et al.
Publicado: (2010)

Identifying Kinase Substrates via a Heavy ATP Kinase Assay and Quantitative Mass Spectrometry
por: Müller, André C., et al.
Publicado: (2016)

A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
por: Fauster, A, et al.
Publicado: (2015)

Cell biology: A key driver of therapeutic innovation
por: Hantschel, Oliver, et al.
Publicado: (2012)

SLC38A9: A lysosomal amino acid transporter at the core of the amino acid-sensing machinery that controls MTORC1
por: Rebsamen, Manuele, et al.
Publicado: (2015)

A structure and evolutionary-based classification of solute carriers
por: Ferrada, Evandro, et al.
Publicado: (2022)

Targeting a cell state common to triple-negative breast cancers
por: Muellner, Markus K, et al.
Publicado: (2015)

Internalization of Pseudomonas aeruginosa Strain PAO1 into Epithelial Cells Is Promoted by Interaction of a T6SS Effector with the Microtubule Network
por: Sana, Thibault G., et al.
Publicado: (2015)

Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line
por: Essletzbichler, Patrick, et al.
Publicado: (2014)

An Inducible Retroviral Expression System for Tandem Affinity Purification Mass-Spectrometry-Based Proteomics Identifies Mixed Lineage Kinase Domain-like Protein (MLKL) as an Heat Shock Protein 90 (HSP90) Client
por: Bigenzahn, Johannes W., et al.
Publicado: (2016)

Targeting allosteric regulatory modules in oncoproteins: “Drugging the Undruggable”
por: Hantschel, Oliver, et al.
Publicado: (2011)

Recent advances in combinatorial drug screening and synergy scoring
por: Pemovska, Tea, et al.
Publicado: (2018)

A guide to plasma membrane solute carrier proteins
por: Pizzagalli, Mattia D., et al.
Publicado: (2020)

Efficient generation and reversion of chromosomal translocations using CRISPR/Cas technology
por: Lekomtsev, Sergey, et al.
Publicado: (2016)

Detection of Chemical Engagement of Solute Carrier Proteins by a Cellular Thermal Shift Assay
por: Hashimoto, Mari, et al.
Publicado: (2018)

The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity
por: Heinz, Leonhard X., et al.
Publicado: (2015)

PTK2B promotes TBK1 and STING oligomerization and enhances the STING-TBK1 signaling
por: Lin, Yongfang, et al.
Publicado: (2023)

The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2)
por: Winger, Jonathan A, et al.
Publicado: (2009)

FUS mutations dominate TBK1 mutations in FUS/TBK1 double-mutant ALS/FTD pedigrees
por: Brenner, David, et al.
Publicado: (2021)

Current themes in molecular pediatrics: molecular medicine and its applications
por: Superti-Furga, Andrea, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_non5ee3kp1knlmuq9c690fbmng